INTRODUCTION
The increasing prevalence of obesity in developed countries is driving research into metabolic diseases, particularly obesity and its associated complications. Metabolically active brown adipose tissue (BAT) in human adults was identified through improved imaging with positron emission tomography combined with computed tomography (PET/CT) (1) (2) (3) (4) (5) . This has led to a paradigm shift in metabolic disease investigations and intensified the scrutiny of BAT as a systemic energy regulator. Studies have demonstrated that the amount of BAT found in adult humans is inversely correlated with body mass index, with the lowest found in obese individuals (5, 6) ; therefore, increasing BAT mass has been proposed as a potential therapy against obesity. Unlike white adipocytes, which are responsible for energy storage, brown adipocytes are responsible for dissipating chemical energy in the form of heat mediated by the function of uncoupling protein-1 (UCP1). UCP1 is responsible for reducing the membrane potential and thereby uncoupling oxidative phosphorylation from ATP synthesis, burning glucose and fatty acids, leading to improved glucose homeostasis and blood lipid profiles (7, 8) . BAT in humans, similar to BAT in rodents, was recently shown to be effectively stimulated by β3-adrenergic receptor agonists (9).
Recent studies have identified two types of thermogenic adipocytes -the classical brown adipocytes and beige adipocytes (10) . Beige adipocytes can be found interspersed among the subcutaneous white adipose tissue (WAT) upon "browning" in response to cold exposure or pharmacological stimuli (11) (12) (13) (14) . Similar to the classical brown adipocytes, beige adipocytes are characterized by multi-locular lipid droplets and express brown fat-specific genes such as Ucp1 and Cidea. Human BAT is more similar to rodent beige fat than it is to classical rodent inter-scapular BAT in molecular characteristics and signatures (10, 15) . Therefore, there is considerable interest in identifying biological mechanisms and new drug molecules capable of stimulating rodent beige fat as a surrogate for human BAT. However, non-invasive pre-clinical imaging tools which enable longitudinal assessment of by guest, on April 23, 2018 www.jlr.org To date, several imaging approaches such as PET/CT and magnetic resonance imaging (MRI) have attempted to quantify BAT in vivo. Although PET/CT imaging has been instrumental in the identification of BAT in humans and is routinely used in functional characterization of BAT activity in rodents, it necessitates exposure to ionizing radiation and thus not suitable for longitudinal studies where repeated scans are required. On the other hand, MRI has been employed for characterizing BAT independent of its metabolic activity, based on the unique chemical-shift water-fat signals due to differences in morphology and chemical composition between WAT and BAT (16) . Despite this development, the reliable localization and quantification of WAT browning can be impeded by its relatively poor resolution and sensitivity, which obfuscate the detection of interspersed beige adipocytes in WAT. To overcome the challenges associated with the aforementioned imaging techniques, PET/MR hybrid imaging modality has been developed as an alternative to PET/CT, which enables the assessment of radio-labeled tracer 2-deoxy-2-18 F-fluoro-D-glucose ( 18 F-FDG) uptake by PET along with the anatomical description measured from MR.
Recent studies have also explored the feasibility of optical imaging for BAT localisation which relatively has ease of use and low cost, making it an attractive modality for preliminary in vivo screening in small animals. Conventional optical imaging techniques, however, are limited by spatial resolution and light scattering in tissues and can be overcome with MSOT-US (17, 18). Previously, near-infrared fluorescent protein (iRFP) engineered from bacterial phytochrome photoreceptors was previously shown to be a good optoacoustic contrast agent due to its high extinction coefficients and low fluorescence quantum yields (19) . The use of iRFP as a reporter protein coupled with MSOT's newly demonstrated capacity to image reporter proteins in deep tissues opens up the possibility of visualizing dynamic molecular and cellular processes (20) (21) (22) . Here, we describe an imaging protocol utilizing MSOT-US to monitor endogenous browning of fat sensitively and non-invasively using a near infrared fluorescent 
MATERIALS AND METHODS

Cell culture
3T3L1 preadipocytes (ATCC) were cultured on gelatin coated plates and maintained in DMEM (Invitrogen, Gibco) supplemented with 10% newborn calf serum and Penicillin-Streptomycin were added to a final concentration of 100 Units/ml. For white adipocyte differentiation, confluent 3T3L1 were cultured in DMEM and 10% fetal bovine serum (FBS) supplemented with 167 nM insulin, 1 mM dexamethasone, 0.5 mM isobutylmethyxanthine for 2 days. After 2 days, the cells were maintained in DMEM and 10% FBS supplemented with 167 nM insulin. On day 4, the medium was changed to DMEM containing 10% FBS until harvest. For induction into brown adipocytes, differentiated 3T3L1 cells were treated with 10 mM Forskolin (FSK) for 6 hrs. HEK293T cells were grown and maintained in DMEM supplemented with 10% FBS and 100 Units/ml Penicillin-Streptomycin. Cultures were maintained at 37°C and 5% CO 2 .
Plasmid constructs
The following expression constructs were purchased from Addgene: piRFP720-N1 (#45461), pAAV-MCS2 (#46954). To generate pAAV-mini/UCP1-iRFP720 reporter construct, the short version of the Ucp1 promoter (mini/Ucp1) and infra-red fluorescent protein (iRFP720) reporter was cloned into the constitutive PGK-iRFP720 lentiviral construct, iRFP720 reporter was cloned downstream of the PGK promoter in pCDH-PGK-MCS-EF1-GFP vector (a kind gift from Dr. Srikanth Nama) using the EcoRI and NotI restriction sites at the 5' and 3' ends, respectively. PGK promoter in PGK-iRFP720 construct was replaced with the mini/Ucp1 promoter using the ClaI and XbaI restriction sites to generate the mini/Ucp1-iRFP720 lentiviral construct.
Lentivirus and adeno-associated virus preparation
Third generation lentivirus was produced by co-transfecting HEK293T cells with 10 µg transfer vector and three packaging plasmids -6.5 µg pMDLg/pRRE, 2.5 µg pRSV-REV, 3.5 µg pMD2.G. Transfection was performed using jetPRIME transfection reagent (Polyplus) as per manufacturer's protocol. Viral supernatant was collected 48 and 72 hours post transfection. Supernatant was purified by filtering through a 0.22 µm low protein binding membrane and concentrated by ultracentrifugation. Viral particles were resuspended in 1X Hank's Balance Salt solution, aliquoted and stored at -80°C. Virus titers were determined by infecting HEK293T with serially diluted virus for 72 hours, followed by flow cytometry analysis of GFP expression. Recombinant adeno-associated virus (rAAV) was produced by cotransfecting HEK293T cells with 3 plasmids -AAV transgene expression plasmid, AAV-2/8 packaging plasmid, and adenoviral helper pF Δ6. AAV expression plasmid encodes iRFP720 driven by the mini/UCP1 promoter. rAAV was packaged and purified as previously described (23) .
Quantitative real-time PCR
Total RNA was extracted with Trizol (Invitrogen) and then purified using RNAeasy (Qiagen) following manufacturer's protocol. Reverse transcription was performed using RevertAid First Strand cDNA Synthesis kit (Fermentas). Gene expression was analyzed using Power SYBR Green PCR Master Mix with StepOne Plus real-time PCR system. Relative gene expession was calculated using the 2 -∆∆CT method and normalized to 18S rRNA expression. Primer sequences used can be found in Supplemental Table S1 .
Western Blotting
7
Tissues were lysed using RIPA buffer with protease and phosphatase inhibitors. Proteins were separated by SDS-PAGE, transferred to nitrocellulose membrane and probed with a-tubulin (1:1000, T5168, Sigma) and UCP1 antibodies (1:1000, ab23841, Abcam).
Fluorescence microscopy
Following browning induction with 10 mM Forskolin for 6 hrs, differentiated adipocytes expressing mini/Ucp1 iRFP720 were imaged using Nikon A1Rsi + confocal laser microscope system with a 100X
NA/1.40 CFI Plan Apo VC oil-immersion objective. Images were analysed using NIS-Elements microscope imaging software.
Animal Procedures
Animal procedures were carried out in accordance to the Institutional Animal Care and Use Committee approved protocol at Biological Resource Centre, Singapore. Mice were kept at room temperature with a 12 hour light-dark cycle and had free access to food and water. Saline or β3-adrenergic receptor agonist CL-316,243 compound (1mg/kg) was intraperitoneally administered daily. BALB/c mice (InVivos) aged 6-8 weeks were anesthetized using 2% isoflurane in O 2 . Once anesthesia was fully induced, the animal was shaved with a hair trimmer in the area where the inguinal WAT (iWAT) was located. The shaved area was sterilized with three alternating wipes of Betadine and 70% ethanol. The adipose tissue was held in place with the forceps, and the recombinant adeno-associated virus (rAAV) was injected (1.0 × 10 10 viral genome (vg) per 20 µl in phosphate-buffered saline) with a 0.3 cc, 31 G insulin syringe. The procedure was repeated on the opposite iWAT to complete the bilateral injection.
In vivo and ex vivo fluorescence imaging
Imaging was performed using the Bruker In-Vivo Xtreme imaging system (Bruker, Germany). 
MSOT imaging and processing
For optoacoustic imaging, an MSOT inVision 512-echo small animal imaging system (iThera Medical GmbH, Munich, Germany) was employed (24) . Details of the imaging system can be found in the 
PET imaging coupled with MRI
The animals were imaged longitudinally on the Mediso nanoscan 3T MR-PET system using a modified version of the methodology described by Wang et al (26) . Briefly, animals were anaesthetised using inhalational isoflurane anaesthesia (maintained at 1.5% alveolar concentration) and injected with 
Histology
Tissues were dissected and fixed with 10% formalin. Fixed tissues were embedded in paraffin and sectioned. Sections were stained with hematoxylin and eosin (H&E) or were probed with antibody for UCP1 (1:100, ab23841, Abcam). Images were taken using Nikon TS-100-F microscope.
Statistical analysis
Data are expressed as means ± SEM. Analyses were performed using Micorsoft Excel or GraphPad Prism. Statistical significance was assessed by two-tailed Student's T-test to analyse the difference between two groups. Statistical significance was defined as P < 0.05. The correlation between PET and MSOT data points was analysed by Pearson correlation which yielded correlation coeeficients and Pvalues.
RESULTS
Development of reporter system for monitoring adipose browning in the optical system
To assess the extent of browning in WAT with optical imaging, we generated a reporter construct in which expression of iRFP720 is driven by short version of the UCP1 (mini/UCP1) promoter (27, 28), which was previously shown to contain the minimal regulatory elements required for transcriptional activity (Fig. 1a) . As a positive control for the iRFP720 activity during in vitro imaging studies, we also generated a DNA construct to express iRFP720 driven by constitutive phosphoglycerate kinase (PGK) promoter (Fig. 1a) . We first validated the reporter activity upon browning stimulation with FSK treatment, following adipogenesis in 3T3L1 preadipocytes transduced with lentivirus encoding the by guest, on April 23, 2018 www.jlr.org Downloaded from respective reporter constructs. Expression of iRFP720 was first confirmed by fluorescence microscopy.
We observed the iRFP720 signal after FSK treatment in 3T3L1 cells stably expressing mini/Ucp1-iRFP720 (Fig. 1b) . In addition, protein lysates were harvested from the transduced 3T3L1 cells treated with either FSK or DMSO control. In concordance with our fluorescence microscopy, we observed induction of the iRFP720 signal in FSK treated cells from both MSOT analysis (Fig. 1c) and optical imaging using Bruker Xtreme system (Fig. 1d) . Furthermore, elevated expression of Ucp1 and other thermogenic genes, but not of adipogenic genes, was observed in mature adipocytes that stably express iRFP720 reporter upon FSK treatment, indicating that the reporter activation does not perturb the normal browning function of cells (Fig. 1e) .
To evaluate the ability of the reporter system to recapitulate induction of Ucp1 expression in WAT during browning, iWAT (inguinal WAT) was administered with rAAV encoding for the mini/Ucp1-iRFP720.
Following treatment with specific β 3 adrenergic receptor agonist CL-316,243, an increase in iRFP720 signals was detected in iWAT in response to chronic CL-316,243 treatment compared to the control treatment with both in vivo ( Fig. 2a and b) and ex vivo imaging ( Fig. 2c and d) . The browning of iWAT was further evidenced by the presence of multilocular adipocytes in CL-316,243 treated animals ( Fig. 2e) ,
suggesting that the Ucp1-iRFP720 reporter accurately mimics changes in Ucp1 elicited during the browning process and thus serves as a useful tool to quantify changes during adipose browning in vivo.
Monitoring the browning process longitudinally by optoacoustic imaging
To further demonstrate that the Ucp1 promoter-driven reporter system is capable of visualizing browning non-invasively in vivo, the expression profile of the iRFP720 protein following rAAV injection was monitored via MSOT before and at several time points after adrenergic stimulation. Optoacoustic signals of iRFP720 protein (pseudo-coloured in magenta) could be discerned at Day 4 and thereafter in mice administered with CL-316,243 (Fig. 3a) . In contrast, iRFP720 fluoresence activity was not detected in saline treated animals (Fig. 3b) . Time course quantification of the iRFP720 optoacoustic signals in the iWAT for CL-316,243 and saline treated animals revealed significant induction of iRFP720 expression at by guest, on April 23, 2018 www.jlr.org
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Day 4 (0.177 ± 0.009 a.u.) post adrenergic stimulation with its peak expression achieved at Day 7 (0.229 ± 0.020 a.u.) before reaching plateau at Day 10 (0.218 ± 0.037 a.u.) (Fig. 3c) .
Next, we hypothesized that enhanced fatty acid oxidation during browning of WAT may result in attenuated lipid distribution during optoacoustic imaging. To examine this, we took advantage of the spectra absorption of the CH 2 group in lipids which allow for the iWAT to be distinguished from the surrounding tissues by optoacoustic imaging. Notably, the lipid signals (pseudo-coloured in green) in iWAT of CL-316,243 treated animals diminished over time during beiging ( Fig. 3a and d) . On the other hand, the lipid signals of the saline treated animals were significantly higher than that of CL-316,243 treated animals at Days 4, 7 and 10 (132 ± 2 a.u. vs. 99 ± 9 a.u., 148 ± 5 a.u. vs. 97 ± 7 a.u., 145 ± 4 a.u.
vs. 90 ± 5 a.u. respectively, *p < 0.05). Furthermore, the reduced lipid signals were observed in close proximity and/or overlapping with optoacoustic iRFP720 activity in the iWAT area (Fig. 3a) , suggesting an increase in UCP1-mediated lipid metabolism during iWAT browning. Consistent with the increase in iRFP720 activity, CL-316,243 treated mice showed a marked increase in multi-locular, beige adipocytes and robust induction of UCP1 protein in iWAT, as demonstrated by histological and immunoblot analyses ( Fig. 3e and f) .
Quantification of adipose browning with FDG-PET imaging coupled with MRI
In order to determine if adipose browning can be monitored and correlated with a clinically translatable system, small animal PET/MR imaging was performed on the same animals following MSOT-US imaging at days 1, 4, 7 and 10 during adrenergic stimulation as shown in Supplemental (Fig. 4b) , indicating that the observed changes in optoacoustic iRFP720 signals are strongly correlated with the 18 F-FDG signals measured by PET imaging during browning.
DISCUSSION
The discovery of brown/beige fat in adult humans has rekindled the interest in its role as a regulator of energy homeostasis and excitement over the possibility of activating browning of WAT to enhance energy expenditure for the treatment of obesity and metabolic diseases. The development of new pharmacological agents that augment browning activity necessitates the use of sensitive and specific preclinical imaging methodologies that are well correlated with Ucp1 expression, which is a marker for browning.
To date, there are a few strategies employed for the development of molecular probes that specifically target BAT. Since BAT is highly vascularized, probes have been developed to exploit this charateristic including IR786 (a lipophilic cationic near infra-red fluorescence dye) and peptide PEP3 (29, 30) . Micelles loaded with SRFluor680 and curcumin analogues have also been proposed as alternative molecular probes specific for BAT (31, 32) . Although these probes have demonstrated some success in in vivo imaging of BAT, they indirectly target vascular cells rather than brown adipocytes of BAT, and the ability of these probes for real time monitoring of browning in WAT remains largely unexplored.
Alternative imaging techniques have attempted to assess surrogates of Ucp1 activation, whereby the transgenic mouse expresses a luciferase gene under the control of a Ucp1 promoter (33, 34) . However, it Though PET/CT imaging with 18 F-FDG has been the gold standard imaging modality for assessing BAT in rodents and humans, the uptake of 18 F-FDG is an indirect measure of glucose uptake, and is often difficult to distinguish between BAT and other metabolically active tissues. By combining PET with MRI that can identify fat depots by T1-weighted images, we demonstrated that the system can reliably assess adipose browning levels, which are well correlated with those measured by the optoacoustic system.
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In conclusion, we demonstrate the utility of the optical system coupled with a novel reporter and PET/MR system with 18 
